A blockbuster unleashed: What happens when a big fat business explodes?
Published on: March 21, 2026, 10:51 a.m. | Source: The Economic Times
India is set to experience a dramatic shift as Ozempic and Wegovy's active ingredient, semaglutide, becomes widely available. Over 40 Indian companies are launching affordable generic versions, slashing prices and expanding access. This transition promises to address major health challenges but also raises concerns about potential misuse and the need for strong oversight.
